CELECOXIB (CELEBREX)

Course overview

Celecoxib is U.S. FDA-approved to treat ankylosing spondylitis, rheumatoid arthritis (RA), juvenile rheumatoid arthritis (JRA; patients ≥ 2 years), osteoarthritis (OA), primary dysmenorrhea, and acute pain. This continuing education module is designed to give the reader/learner an increased understanding of celecoxib. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.